Basic Research
The studies of cobalt nanoparticles on the toxicity and biological activity of osteoclast
Liu Yake, Wang Wei, Ye Jun, Yang Hongwei, Han Qinglin, Tao Ran, Liu Fan
Published 2015-12-01
Cite as Chin J Orthop, 2015,35(12): 1253-1258. DOI: 10.3760/cma.j.issn.0253-2352.2015.12.011
Abstract
ObjectiveTo explore the toxicity and biological activity of cobalt nanoparticles (CoNPs) on osteoclasts, and to analyze the relationship between cobalt nanoparticles and osteolysis.
MethodsFrom November 2014 to July 2015, RAW264.7 cell was induced to osteoclastlike cell by LPS. Different concentrations of cobalt nanoparticles and cobalt chloride were added, and the cell morphology was observed under a microscope. 24 h after induction on RAW264.7, cells were grouped in- to cobalt nanoparticles group (10, 20, 50, 100 μmol/L), cobalt chloride group (10, 20, 50, 100 mol/L) and control group. MTT assessment and Q-PCR were performed at 2 h, 4 h, 8 h, 24 h, 48 h post-treatment.
ResultsWith the increase of concentration (10, 20, 50, 100 μmol/L) and the action time (2 h, 4 h, 8 h, 24 h, 48 h), the inhibition rate of cobalt nanoparticles and cobalt chloride on osteoclast like cells was significantly increased, and the inhibition rate of cobalt nanoparticles was higher. With different concentrations (10, 20, 50, 100 μmol/L) of CoNPs and cobalt chloride, the relative expression of CAII, Cat K gene mRNA expression decreased compared with the control group, when the concentration of CoNPs was in the range of 10-50 μmol/L, the relative expression of CAII and Cat K was increased, which was reduced in cobalt chloride group.
ConclusionDifferent concentrations of cobalt nanoparticles and cobalt chloride can inhibit the proliferation and differentiation of osteoclasts, and cobalt nanoparticles is more pronounced, when the concentration of cobalt nanoparticles was 10-50 μmol/L, the relative expression of osteoclasts CAII, Cat K increaseed, which was suppressed at the same concentration of cobalt chloride.
Key words:
Osteoclasts; Cobalt; Toxic actions
Contributor Information
Liu Yake
Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong 226001, China
Wang Wei
Institute of Orthopaedic Surgery, Nantong University, Nantong 226019, China Liu Yake and Wang Wei are the first authors who contributed equally to the article
Ye Jun
Yang Hongwei
Han Qinglin
Tao Ran
Liu Fan